1. Strategy for linker selection to enhance refolding and bioactivity of VAS-TRAIL fusion protein based on inclusion body conformation and activity
   Jiying Fan et al, 2015, Journal of Biotechnology CrossRef
2. Genetically engineered recombinant adenovirus expressing interleukin‑2 for hepatocellular carcinoma therapy
   Yunpeng Sun et al, 2017, Molecular Medicine Reports CrossRef
3. Overexpression of p53 delivered using recombinant NDV induces apoptosis in glioma cells by regulating the apoptotic signaling pathway
   Xiaoyong Fan et al, 2018, Experimental and Therapeutic Medicine CrossRef
4. CRISPR/Cas9 in cancer therapy: A review with a special focus on tumor angiogenesis
   Krishnasamy naidu gopal Hariprabu et al, 2021, International Journal of Biological Macromolecules CrossRef
5. Grim-19 expressed by recombinant adenovirus for esophageal neoplasmtarget therapy
   Jianxiang Song et al, 2018, Molecular Medicine Reports CrossRef
6. Galectin-9 and Interferon-Gamma Are Released by Natural Killer Cells upon Activation with Interferon-Alpha and Orchestrate the Suppression of Hepatitis C Virus Infection
   Anna Paola Carreca et al, 2022, Viruses CrossRef
7. Efficient refolding of the bifunctional therapeutic fusion protein VAS-TRAIL by a triple agent solution
   Jiying Fan et al, 2016, Protein Expression and Purification CrossRef
8. Tumor angiogenesis and anti‑angiogenic gene therapy for cancer (Review)
   Tinglu Li et al, 2018, Oncology Letters CrossRef
9. Recombinant adenovirus expressing a dendritic cell‑targeted melanoma surface antigen for tumor‑specific immunotherapy in melanoma mice model
   Li‑Li Guo et al, 2018, Experimental and Therapeutic Medicine CrossRef